ZEVRA THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Zevra Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2014 to Q3 2024.
  • Zevra Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $512K, a 246% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $512K +$364K +246% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $875K +$822K +1551% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.79M +$1.73M +3270% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $94K +$41K +77.4% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $148K -$291K -66.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $53K -$387K -88% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $53K -$384K -87.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $53K -$385K -87.9% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $439K $0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $440K +$3K +0.69% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $437K $0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $438K $0 0% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $439K +$1K +0.23% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $437K -$90K -17.1% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $437K -$90K -17.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $438K -$89K -16.9% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $438K -$88K -16.7% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $527K -$21K -3.83% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $527K -$28K -5.05% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $527K -$35K -6.23% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $526K +$343K +187% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $548K -$702K -56.2% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $555K -$1.09M -66.3% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $562K +$356K +173% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $183K -$130K -41.5% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $1.25M +$929K +289% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $1.65M +$1.39M +533% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $206K -$154K -42.8% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $313K -$159K -33.7% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $321K +$210K +189% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $260K +$151K +139% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 $360K +$251K +230% Dec 31, 2016 10-K 2018-03-30
Q3 2016 $472K +$273K +137% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $111K +$55K +98.2% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $109K -$1.95M -94.7% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 $109K -$1.51M -93.3% Dec 31, 2015 10-K 2017-03-10
Q3 2015 $199K Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $56K Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $2.06M Mar 31, 2015 10-Q 2015-05-29
Q4 2014 $1.62M Dec 31, 2014 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.